180 related articles for article (PubMed ID: 7671240)
21. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
[TBL] [Abstract][Full Text] [Related]
22. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
[TBL] [Abstract][Full Text] [Related]
23. GFAP promoter elements required for region-specific and astrocyte-specific expression.
Lee Y; Messing A; Su M; Brenner M
Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter.
Vandier D; Rixe O; Besnard F; Kim M; Rikiyama T; Goldsmith M; Brenner M; Gouyette A; Cowan KH
Cancer Gene Ther; 2000 Aug; 7(8):1120-6. PubMed ID: 10975672
[TBL] [Abstract][Full Text] [Related]
25. Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter.
Chiu IM; Touhalisky K; Liu Y; Yates A; Frostholm A
Oncogene; 2000 Dec; 19(54):6229-39. PubMed ID: 11175337
[TBL] [Abstract][Full Text] [Related]
26. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
McKie EA; Graham DI; Brown SM
Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
[TBL] [Abstract][Full Text] [Related]
27. Interaction of simian virus 40 with human glioma cells.
Fischer H; Schwechheimer K
Hum Neurobiol; 1983; 2(2):59-64. PubMed ID: 6313555
[TBL] [Abstract][Full Text] [Related]
28. Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40 T antigen transgenic mice.
Penna D; Schmidt A; Beermann F
Oncogene; 1998 Nov; 17(20):2601-7. PubMed ID: 9840923
[TBL] [Abstract][Full Text] [Related]
29. GFAP-expressing cells in the postnatal subventricular zone display a unique glial phenotype intermediate between radial glia and astrocytes.
Liu X; Bolteus AJ; Balkin DM; Henschel O; Bordey A
Glia; 2006 Oct; 54(5):394-410. PubMed ID: 16886203
[TBL] [Abstract][Full Text] [Related]
30. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
31. Use of GFAP-lacZ transgenic mice to determine astrocyte fate in grafts of embryonic ventral midbrain.
Quintana JG; Lopez-Colberg I; Cunningham LA
Brain Res Dev Brain Res; 1998 Jan; 105(1):147-51. PubMed ID: 9497089
[TBL] [Abstract][Full Text] [Related]
32. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells.
Rutka JT; Hubbard SL; Fukuyama K; Matsuzawa K; Dirks PB; Becker LE
Cancer Res; 1994 Jun; 54(12):3267-72. PubMed ID: 8205549
[TBL] [Abstract][Full Text] [Related]
33. Haploid male germ cells show no susceptibility to transformation by simian virus 40 large tumour antigen in transgenic mice.
Nayernia K; Samani AA; Klaproth S; Engel W
Cell Biol Int; 1998; 22(6):437-43. PubMed ID: 10328852
[TBL] [Abstract][Full Text] [Related]
34. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
[TBL] [Abstract][Full Text] [Related]
35. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
36. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.
Penkowa M; Camats J; Giralt M; Molinero A; Hernández J; Carrasco J; Campbell IL; Hidalgo J
Glia; 2003 May; 42(3):287-306. PubMed ID: 12673834
[TBL] [Abstract][Full Text] [Related]
37. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage.
Raponi E; Agenes F; Delphin C; Assard N; Baudier J; Legraverend C; Deloulme JC
Glia; 2007 Jan; 55(2):165-77. PubMed ID: 17078026
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor-I regulates glial fibrillary acidic protein gene expression in astrocytes differentiated from cortical precursor cells.
Cebolla B; Vallejo M
J Neurochem; 2006 May; 97(4):1057-70. PubMed ID: 16606365
[TBL] [Abstract][Full Text] [Related]
39. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
[TBL] [Abstract][Full Text] [Related]
40. The promoter of the human cystic fibrosis transmembrane conductance regulator gene directing SV40 T antigen expression induces malignant proliferation of ependymal cells in transgenic mice.
Perraud F; Yoshimura K; Louis B; Dalemans W; Ali-Hadji D; Schultz H; Claudepierre MC; Chartier C; Danel C; Bellocq JP
Oncogene; 1992 May; 7(5):993-7. PubMed ID: 1373882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
